|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/519 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12N 9/99 | (2006.01) | ||
| C12N 9/99 | (2013.01) |
| (11) | Patento numeris | 3677266 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18851555.5 |
| Europos patento paraiškos padavimo data | 2018-08-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-07-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2018/032314 |
| Data | 2018-08-31 |
| (87) | Numeris | WO 2019/045036 |
| Data | 2019-03-07 |
| (30) | Numeris | Data | Šalis |
| 2017168606 | 2017-09-01 | JP |
| (72) |
ABE, Naomi , JP
HASAKO, Shinichi , JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd. ,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444,
JP
|
| (54) | EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR |
| EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR |